The global Lung Cancer Therapeutics Market is anticipated to bode well over the forecast period by registering a total CAGR of 13.4% from 2022 to 2032. The global market is projected to reach US$ 48,725.9 Million by 2026. In addition to rising regulatory approvals and the acceptance of modern treatments in Europe, t.
/PRNewswire/ Major players in the anti-obesity market are F. Hoffmann-La Roche AG, GlaxoSmithKline PLC, BoehringerIngelheim GmbH, and Pfizer Inc., Merck &.